High materiality8/10
Tango Therapeutics price target raised to $69 from $55 at Leerink
Why it may matterVerify against the original reporting
bullish_upgrade
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Leerink raises Tango Therapeutics price target to $69 from $55; current price $31.17; upside substantial.
- PT $69; price $31.17; upside large.
Key facts
- 01
Target: $69
- 02
Posted price: $31.17
- 03
Analyst firm: Leerink Partners
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.